JP2005519073A5 - - Google Patents

Download PDF

Info

Publication number
JP2005519073A5
JP2005519073A5 JP2003567333A JP2003567333A JP2005519073A5 JP 2005519073 A5 JP2005519073 A5 JP 2005519073A5 JP 2003567333 A JP2003567333 A JP 2003567333A JP 2003567333 A JP2003567333 A JP 2003567333A JP 2005519073 A5 JP2005519073 A5 JP 2005519073A5
Authority
JP
Japan
Prior art keywords
compound according
compound
group
metabolite
sleep
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003567333A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005519073A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/001845 external-priority patent/WO2003068148A2/en
Publication of JP2005519073A publication Critical patent/JP2005519073A/ja
Publication of JP2005519073A5 publication Critical patent/JP2005519073A5/ja
Withdrawn legal-status Critical Current

Links

JP2003567333A 2002-01-18 2003-01-21 睡眠標的モジュレーターを使用する睡眠障害の治療 Withdrawn JP2005519073A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34991202P 2002-01-18 2002-01-18
US35732002P 2002-02-15 2002-02-15
PCT/US2003/001845 WO2003068148A2 (en) 2002-01-18 2003-01-21 Treatment of sleep disorders using sleep target modulators

Publications (2)

Publication Number Publication Date
JP2005519073A JP2005519073A (ja) 2005-06-30
JP2005519073A5 true JP2005519073A5 (https=) 2005-12-22

Family

ID=27737408

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003567333A Withdrawn JP2005519073A (ja) 2002-01-18 2003-01-21 睡眠標的モジュレーターを使用する睡眠障害の治療

Country Status (6)

Country Link
US (2) US20030232839A1 (https=)
EP (1) EP1471913A2 (https=)
JP (1) JP2005519073A (https=)
AU (1) AU2003210598A1 (https=)
CA (1) CA2473586A1 (https=)
WO (1) WO2003068148A2 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR047759A1 (es) * 2003-09-26 2006-02-22 Vertex Pharma Derivados de fenil - piperazina como moduladores de receptores muscarnicos
US20080167248A1 (en) * 2004-04-26 2008-07-10 Immuneregen Biosciences, Inc. Anti-Aging Effects Of Substance P
JP4613031B2 (ja) * 2004-05-06 2011-01-12 エスエス製薬株式会社 催眠剤組成物
PT1931346E (pt) * 2005-09-09 2012-08-14 Angelini Labopharm Llc Composição de trazodona para administração uma vez por dia
WO2007048219A2 (en) * 2005-09-09 2007-05-03 Labopharm Inc. Sustained drug release composition
WO2007098200A2 (en) 2006-02-16 2007-08-30 Imthera Medical, Inc. An rfid-based apparatus, system, and method for therapeutic treatment of obstructive sleep apnea
WO2008070795A2 (en) * 2006-12-06 2008-06-12 Somaxon Pharmaceuticals, Inc. Combination therapy using low-dose doxepin for the improvement of sleep
EP2197536A1 (en) 2007-10-09 2010-06-23 Imthera Medical, Inc. System and method for neural stimulation
BRPI0920548B8 (pt) 2008-10-09 2021-06-22 Imthera Medical Inc aparelho para controlar posição da língua de um paciente
ATE522169T2 (de) 2009-10-23 2011-09-15 Gruppo Cimbali Spa Kaffeemaschine mit abgabedruckregulierung und damit zusammenhängendes verfahren
JP2013509943A (ja) 2009-11-10 2013-03-21 イムセラ・メディカル・インコーポレーテッド 舌下神経を刺激して患者の舌の位置を調節するシステム
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
WO2012109216A1 (en) 2011-02-11 2012-08-16 Zx Pharma, Llc Multiparticulate l-menthol formulations and related methods
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
US20120315337A1 (en) * 2011-06-07 2012-12-13 Shah Syed Multiparticulate 5-htp compositions and related methods
US9266881B2 (en) 2011-11-14 2016-02-23 Merck Sharp & Dohme Corp. Triazolopyridinone PDE10 inhibitors
CA2909591C (en) 2013-04-23 2017-03-28 Zx Pharma, Llc Enteric coated multiparticulate composition with proteinaceous subcoat
KR102597910B1 (ko) 2015-03-26 2023-11-02 재클린 엠. 이베르센 숙취상태와 연관된 증상들을 억제하기 위한 방법 및 조성물
HUE058725T2 (hu) * 2018-04-06 2022-09-28 Basf Se Eljárás aminok elõállítására
WO2024102458A1 (en) * 2022-11-11 2024-05-16 Gilgamesh Pharmaceuticals, Inc. Methods of using trazodone to reverse the effects of 5-ht2a receptor agonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116852A (en) * 1990-12-03 1992-05-26 Bristol-Myers Squibb Co. Treatment of sleep disorders

Similar Documents

Publication Publication Date Title
JP2005519073A5 (https=)
JP2010523476A5 (https=)
JP2011515482A5 (https=)
JP2014051526A5 (https=)
JP2009143956A5 (https=)
JP2011509309A5 (https=)
JP2014507455A5 (https=)
JP2018135343A5 (https=)
JP2011519854A5 (https=)
JP2009531277A5 (https=)
JP2014508811A5 (https=)
JP2010504343A5 (https=)
JP2007508361A5 (https=)
ME02766B (me) Derivati arilmetoksi izoindolina i kompozicije koje ih obuhvataju i postupci njihove primene
JP2010503688A5 (https=)
JP2005508349A5 (https=)
ME01421B (me) 5-supstituisani derivati kinazolinona kao protivtumorska sredstva
JP2014506907A5 (https=)
JP2007523155A5 (https=)
JP2013537203A5 (https=)
JP2007508360A5 (https=)
JP2019519587A5 (https=)
JP2013544860A5 (https=)
JP2015517555A5 (https=)
JP2005539045A5 (https=)